[HTML][HTML] Health care practitioners' responsibility to address intimate partner violence related to the COVID-19 pandemic
NL Bradley, AM DiPasquale, K Dillabough… - Cmaj, 2020 - Can Med Assoc
E610 CMAJ| JUNE 1, 2020| VOLUME 192| ISSUE 22 none exist currently. The EDUCATE
program (www. ipveducate. com/the-educate-training-program) is a multimodal training …
program (www. ipveducate. com/the-educate-training-program) is a multimodal training …
A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND. 191
AE Hay, A Murugesan, AM DiPasquale… - Leukemia & …, 2016 - Taylor & Francis
Although outcomes for patients with multiple myeloma have improved, it remains an incurable
malignancy for which new therapies are needed. At a cellular level the Aurora kinases …
malignancy for which new therapies are needed. At a cellular level the Aurora kinases …
Cases of early infectious flexor tenosynovitis treated non-surgically with antibiotics, immobilization, and elevation
AM DiPasquale, EM Krauss, A Simpson… - Plastic …, 2017 - journals.sagepub.com
Background: Early infectious flexor tenosynovitis has been treated with urgent surgery by
most surgeons since Bunnell wrote the first textbook of hand surgery in 1945. Some surgeons …
most surgeons since Bunnell wrote the first textbook of hand surgery in 1945. Some surgeons …
Flat epithelial atypia: are we being too aggressive?
A DiPasquale, S Silverman, E Farag… - Breast Cancer Research …, 2020 - Springer
Purpose The malignant upgrade rate of flat epithelial atypia (FEA) diagnosed on core needle
biopsy varies between 0 and 30%. Excision versus observation with radiological follow-up …
biopsy varies between 0 and 30%. Excision versus observation with radiological follow-up …
[HTML][HTML] Clinical and patient-reported outcomes in oncoplastic breast conservation surgery from a single surgeon's practice in a busy community hospital in Canada
A DiPasquale, Z Prus-Czarnecka… - Canadian Journal of …, 2022 - ncbi.nlm.nih.gov
Background: Oncoplastic breast surgery aims to maintain quality of life by pre-empting and
mitigating against breast asymmetry while not compromising oncological effectiveness. This …
mitigating against breast asymmetry while not compromising oncological effectiveness. This …
Presence of non-classic LCIS is not a contraindication to breast conservation in patients with concomitant invasive breast cancer or DCIS
…, FD Katlin, SC Grossmith, A DiPasquale… - Annals of Surgical …, 2022 - Springer
Background Non-classic lobular carcinoma in situ (NC-LCIS) represents a spectrum of
lesions, histologically distinct from classic LCIS (C-LCIS) and ductal carcinoma in situ (DCIS). …
lesions, histologically distinct from classic LCIS (C-LCIS) and ductal carcinoma in situ (DCIS). …
Clinical and patient-reported outcomes in oncoplastic breast conservation surgery from a single surgeon's practice in a busy community hospital in Canada
A DiPasquale, L Peiris… - Canadian Journal of …, 2021 - search.proquest.com
Background: Oncoplastic surgery aims to maintain quality of life by pre-empting and mitigating
against breast asymmetry while not compromising oncologic effectiveness. Although it is …
against breast asymmetry while not compromising oncologic effectiveness. Although it is …
Abstract PS14-09: The impact of non-classic LCIS on the natural history of DCIS
F Nakhlis, F Katlin, S Grossmith, A DiPasquale… - Cancer Research, 2021 - AACR
Background: Classic lobular carcinoma in situ (C-LCIS) and non-classic LCIS (NC-LCIS) are
histologically and biologically distinct types of lobular neoplasia. Little is known about the …
histologically and biologically distinct types of lobular neoplasia. Little is known about the …
Abstract PS1-61: Clinical and patient reported outcomes in oncoplastic breast conservation surgery from a single surgeon's practice in a busy community hospital in …
A DiPasquale, Z Prus-Czarnecka, L Delmar, L Peiris - Cancer Research, 2021 - AACR
Introduction: Oncoplastic breast surgery combines oncologic partial mastectomy with
ipsilateral defect repair using volume displacement and volume replacement techniques with …
ipsilateral defect repair using volume displacement and volume replacement techniques with …
Cystic hypersecretory ductal carcinoma (CHDC): a rare distinctive variant of ductal carcinoma
A DiPasquale, L Peiris, S Silverman - BMJ Case Reports CP, 2021 - casereports.bmj.com
Cystic hypersecretory ductal carcinoma (CHDC) is a rare distinctive variant of ductal carcinoma
that behaves in a low-grade fashion. This rare form of breast malignancy has only been …
that behaves in a low-grade fashion. This rare form of breast malignancy has only been …